Clinical Trials Directory

Trials / Completed

CompletedNCT02459704

Semilunar Coronally Positioned Flap With or Without Enamel Matrix Derivative for the Treatment of Gingival Recessions

Semilunar Coronally Positioned Flap With or Without Enamel Matrix Derivative for the Treatment of Miller Class I Gingival Recessions: Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Campinas, Brazil · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The aim of this study will be evaluate clinically the use of the Semilunar Coronally Positioned Flap (SCPF) for the treatment of gingival recessions, with or without Enamel Matrix Derivative (EMD). Thirty patients will be assigned in two groups. Half of patients will receive EMD associated to SCPF, while the other half, will receive SCPF alone.

Detailed description

The aim of this study will be evaluate clinically the use of the Semilunar Coronally Positioned Flap (SCPF) for the treatment of gingival recessions, with or without Enamel Matrix Derivative (EMD). Thirty patients will be selected, randomized and allocated in two groups: test group (SCPF + EMD) and control group (SCPF). The subjects will should present buccal Miller class I gingival recessions with height greater than or equal to 2.0 mm and less than to 4.0 mm in maxillary canines or premolars. Clinical parameters will be evaluated: gingival recession height (GRH), gingival recession width(GRW), clinical attachment level (CAL), probing depth (PD), height (HKT) and thickness (TKT) of keratinized tissue and papillas height (HP) and width(LP), as well as plaque and gingival index. These data will be collected at baseline and 180 days after surgery.

Conditions

Interventions

TypeNameDescription
PROCEDURESemilunar coronally positioned flapSemilunar coronally positioned flap with enamel matrix derivative (Emdogain) or alone.
DEVICEEnamel matrix derivative (Emdogain)Enamel matrix derivative associated to semilunar coronally positioned flap (SCPF + EMD - test group)

Timeline

Start date
2014-06-01
Primary completion
2015-06-01
Completion
2015-08-01
First posted
2015-06-02
Last updated
2015-10-08

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02459704. Inclusion in this directory is not an endorsement.

Semilunar Coronally Positioned Flap With or Without Enamel Matrix Derivative for the Treatment of Gingival Recessions (NCT02459704) · Clinical Trials Directory